Theratopix Pharma SA

Dissolution volontaire – liquidation 0.3 FTE

Theratopix Pharma reported revenue of 20,376 € for the 2025 financial year (annual accounts filed with the NBB on 16 Oct 2026), with 0.3 full-time equivalent.

Company number (CBE) 0738.446.251 · VAT BE0738446251
4000 Liège
active in Manufacture of other pharmaceutical products (NACE 21209)
operating since 26 Nov 2019 (≈ 7 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Theratopix Pharma shows with a free account.

See the score
Profile
SA Micro · 0.3 FTE since 2019
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue20,376 €
Net result−436,443 €
Equity−110,818 €
Cash25,174 €
EBITDA−630,057 €
Total assets146,427 €
Headcount (avg FTE)0.3
Solvency-75.7%
The line marks its sector median: 42.6% (57 companies).

Change 2022 → 2025: Revenue -49 % Total assets -79 % Headcount (avg FTE) -83 %

Accounts of the company itself (not consolidated).

The full file covers 6 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Theratopix Pharma's annual accounts

20252024202320222021
Revenue20,376 €
Net result−436,443 €
Equity−110,818 €
Cash25,174 €
EBITDA−630,057 €
Total assets146,427 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 16 Oct 2026
  • Year ended 31 Dec 2024filed on 20 Jun 2025
  • Year ended 31 Dec 2023filed on 14 Jun 2024
  • Year ended 31 Dec 2022filed on 09 Jun 2023
  • Year ended 31 Dec 2021filed on 30 May 2022

Theratopix Pharma's financial analysis

Management and control of Theratopix Pharma

10 active director(s) in the register.

and 4 more

Theratopix Pharma's shareholders and holdings →

Theratopix Pharma's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0738.446.251
VAT number
BE0738446251
Peppol
Registered · 0208:0738446251 · as of 10 Nov 2026
Legal form
SA
Incorporated
26 Nov 2019
Registered office
4000 Liège
Size
Micro · 0.3 FTE
Latest accounts
2025 · filed on 16 Oct 2026
Activity
Manufacture of other pharmaceutical products (NACE 21209)

Theratopix Pharma (SA) has been based in Liège since 2019, active in: manufacture of other pharmaceutical products. For 2025, it reports revenue of 20,376 €, a net loss of 436,443 € and equity of −110,818 €. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -75.7%, below the median of its sector (42.6%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Theratopix Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Theratopix Pharma

What is the revenue of Theratopix Pharma?

According to the 2025 annual accounts filed with the NBB, the revenue of Theratopix Pharma amounts to 20,376 €.

What is the VAT number of Theratopix Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0738446251 for Theratopix Pharma, if the company is VAT-registered. Its company number (CBE) is 0738.446.251.

Where is the registered office of Theratopix Pharma?

According to the CBE register, the registered office of Theratopix Pharma is in 4000 Liège.

What is the equity of Theratopix Pharma?

At the close of the 2025 financial year, the equity of Theratopix Pharma amounts to -110,818 €, a solvency of -75.7% of total assets.

How many people work at Theratopix Pharma?

0.3 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Theratopix Pharma?

The register lists 10 active mandates at Theratopix Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Theratopix Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 22 Oct 2026

No credit card, no commitment.

What each plan unlocks →